Woman's Health Hospital
Asyut, 71111, Egypt
NCT Number: NCT04683562
Netrin-1 is a secreted protein, which was first identified as a neuronal guidance factor. It is expressed in a multitude of tissues as pancreas, lung, breast, and placenta. Netrin-1 is a multifunctional protein, involved in cell polarity, adhesion, angiogenesis, apoptosis, migration, morphogenesis, and differentiation of various cell types. Most of netrin-1 activity occur through signaling pathways induced by its two main receptors, DCC (deleted in colorectal cancer) and UNC5H (uncoordinated-5 homolog). Its receptors have been linked to the processes of apoptosis and angiogenesis. In absence of netrin-1, DCC and UNC5H receptors lead to apoptosis. In contrary, in presence of netrin-1, receptors transduce molecular cascades leading to proliferation, differentiation and migration of the cells. Netrin-1 has been involved in the pathogenesis of multiple diseases, as diabetes, cardiovascular diseases, and cancer. Serum Netrin-1 levels were high in preeclamptic patients.
Looking for future studies?
Notify Me20 year–40 year
Female
Interventional
Not applicable
Asyut, 71111, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pregnant women at gestational age 28-32 weeks
women delivered at term
Time frame: 4 weeks
will be measured by using enzyme-linked immunosorbent assay (ELİSA) in placental homogenate
Assiut University
Other
The Implication of Placental Netrin-1 Receptor DCC in the Pathophysiology of Placenta Accreta
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07662187
Conservative Management, Female Urogenital Diseases and Pregnancy Complications
Sohag, Egypt
View Trial DetailsNCT02729974
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
View Trial DetailsNCT02302573
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Poitiers, France
View Trial DetailsNCT06220760
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Asyut, Asyut Governorate, Egypt
View Trial Details